Les meilleurs doctors traitant la maladie suivante : Perte auditive neurosensorielle - TOP -98 des médecins

Dr. Hilmi Cem Kaya is an experienced ENT specialist. He earned his medical degree from Ege University Faculty of Medicine. He completed his ENT specialization at Uludağ University. Both universities are well-known for their strong medical programs.

Dr. Kaya has worked at top hospitals in Turkey. He served at Sultan Abdulhamid Han Training and Research Hospital in 2023. He also worked at Martyr Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital from 2021 to 2022. During this time, he gained skills in advanced surgical techniques and patient care.

He is known for his expertise in modern, minimally invasive ENT treatments. Dr. Kaya achieves high success rates in his treatments. He stays up to date with the latest research and training to provide the best care for his patients.

CURRICULUM VITAE

VOLKERT B. WREESMANN MD PhD

Consultant Otolaryngologist

Oncologic Head and Neck Surgeon

Thyroid and Parathyroid Surgeon

Facial Plastic Surgeon

Principal Positions

• Centro Medico Teknon, Barcelona, Spain

Chairman, Department of Otolaryngology-Head and Neck Surgery

July 1st 2024 – present

• Juaneda, Ciutadella Menorca, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

January 2025 – present

• Avantmedic, Lleida, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

July 1st 2024 – present

• Clinica Omega Zeta, Andorra

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2022 – present

• University Hospitals Dorset NHS Foundation Trust

Consultant Otolaryngologist-Head and Neck Surgeon

August 1st 2021 – October 1st 2023

• Oxford University Hospitals NHS Foundation Trust

Honorary Consultant Otolaryngologist-Head and Neck Surgeon

May 1st 2021 – April 30th 2024

• Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Consultant Otolaryngologist-Head and Neck Surgeon

July 18th 2016 – April 30th 2021

• Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Consultant Otolaryngologist-Head and Neck Surgeon

November 7th 2015 – May 31st 2016

• Heart of England NHS Trust, Birmingham, UK

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2015 – October 31st 2015

• University Medical Center Utrecht, Netherlands

Consultant Otolaryngologist-Head and Neck Surgeon

November 1st 2013 – June 1st 2014

Memberships

• American Head and Neck Society – Member

Netherlands Academy of Otolaryngology - Member

Professional Licences

• United Kingdom

GMC Certification

Fully Registered Medical Practitioner with Specialist Registration with a License to Practice

Registered: 02/02/2015

GMC # 7499626

• United States of America

New York State Department of Health

New York State Education Department

Registered: July 2011

License# P80949

Physician

• Netherlands

Dutch Ministry of Health (BIG Registration)

BIG Registered: 22-06-2005

BIG #19063373601

Physician

Dutch Specialist Board (RGS)

RGS registered: 01-02-2011

RGS #1911979

Otolaryngology-Head and Neck Surgeon

• Spain

Collegi de Metges de Barcelona

COMB: 63638

• Andorra

Collegi de Metges d’Andorra

RPS: 03098

COMA: 876

Education

• Memorial Sloan-Kettering Cancer Center

Surgical Fellowship, Head and Neck Surgery

New York, New York, USA

August 1st 2011 - July 31st 2013

600 bed dedicated cancer center

Performed 1200 major oncologic head and neck resections in 2 years

• United States of America ECFMG Certification

United States Medical Licensing Examination (USMLE)

Certification: June 22nd, 2010

Scores: 

   Step I: 244/99 

   Step IIa-Clinical knowledge: 227/94

   Step IIb-Clinical Skills: PASSED

   Step III: 206/85

• Netherlands Cancer Institute

Surgical Fellowship, Head and Neck Surgery

Amsterdam, The Netherlands

February 1st 2011 - July 31st 2011

Specialized Head and Neck Cancer Surgery Department

200 bed hospital

• Amsterdam University Medical Center/Netherlands Cancer Institute

Residency Training, Otolaryngology-Head and Neck Surgery

Amsterdam, the Netherlands

February 1st 2006 – January 31st 2011

• University of Amsterdam School of Medicine

Medical Doctor (MD)

Amsterdam, the Netherlands

December 2002 - January 28th 2005

• University of Amsterdam

Doctor of Philosophy (PhD), Molecular Biology

Amsterdam, the Netherlands

Thesis title: Molecular-cytogenetic characterization of head and neck cancer

December 2nd, 2004

• Erasmus University School of Medicine

Doctoral Degree in Medicine

Rotterdam, the Netherlands

September 1994 - November 17th, 1998

Research Training

• Memorial Sloan-Kettering Cancer Center

Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, New York, New York, USA

Research Fellowship in Molecular Oncology

Supervisors: Dr. Bhuvanesh Singh MD, PhD and Dr. Jatin P. Shah, MD, FACS

March 1st 1999 - September 30st 2002

• University of California San Francisco (UCSF)

Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA

Post-doctoral Research Fellowship in Head and Neck Oncology

Supervisors: Dr. Steven Wang MD And Prof David Eisele MD

February 2005 - January 2006

Academic Activities

University of Amsterdam

Doctorate Examination Committee member

• September 17th, 2013 - PhD Candidate: Dr. I.J. Nixon (United Kingdom)
• October 17th 2014 - PhD Candidate: Dr. J. Pramana (Netherlands)
• November 17th 2015 - PhD candidate: Dr. H. van Monsjou (Netherlands)
• December 11th 2018 - PhD Candidate: Dr. Tihana Ibrahimpasic (United States)
• January 18th, 2021 - PhD Candidate: Dr. Laura Wang (Australia)
• June 2nd, 2021 - PhD Candidate: Dr. Caroline Verhagen (Netherlands)

Conference Faculty

• Advanced Laryngopharyngeal Cancer: Functional Preservation and Rehabilitation, Portsmouth, June 25th - 26th, 2020 (postponed due to COVID) - Chairman
• Functional Preservation and Rehabilitation after Treatment for Advanced Laryngeal Cancer, Portsmouth, March 14th - 15th, 2019 - Chairman
• Portsmouth Parathyroid Conference, Portsmouth, December 14th 2018 – Chairman

Editorial Roles

• European Journal of Surgical Oncology

Associate Editor

January 1st 2023 – present

• European Journal of Surgical Oncology

Guest Editor

March issue 2018, Volume 44, Issue 3, p275-378 - Special issue on thyroid cancer management

• Journal of Oral Pathology and Medicine

Guest Editor

November issue 2021, Volume 51, Issue 10 - Special issue on vascular malformations and tumors of the head and neck

• Scientific Journal Reviewer

Oral Oncology, European Journal of Surgical Oncology, Journal of Surgical Oncology, Head and Neck, International Journal of Cancer

• Scientific Project and Grant Reviewer

Netherlands: Dutch Cancer Society

France: Institute National du Cancer

Awards

• New York Head and Neck Society

Annual Meeting, New York, NY, March 2002

Title of study presented: “MUC1 is a target if 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer”

Invited Lectures

• European Society of Surgical Oncology meeting, Krakow, 2016
• Barcelona Society of Neurosurgery, Annual Meeting, Baqueira, Spain, February, 2017
• University of Edinburgh, Department of Otolaryngology Academic Conference, March 17th 2017
• Medilex: Performance of Medical Specialists, Zeist, Netherlands, November 9th 2017
• Medilex: Performance of Medical Specialists, Driebergen, Netherlands, October 11th 2017
• Wessex Head and Neck and Thyroid Network Education Day, May 3rd, 2017
• Portsmouth Parathyroid Conference, Portsmouth, UK, December 14th 2018
• Global Post-laryngectomy Rehabilitation Academy, Portsmouth, UK, March 14th 2019
• Health Care Quality Conference, Beverwijk, Netherlands, March 25th, 2019

Published Research Reports

• The growing precision of diagnostic pathways in thyroid nodule evaluation. 

Bekker J, Wreesmann VB. 

Eur J Surg Oncol. 2025 Jan;51(1):109374.

• Special issue: Management of vascular tumors and malformations of the head and neck. 

Oomen KPQ, Brennan PA, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):829.

• Angiosarcomas of the head and neck: Impact of large data analysis on clinical management.
•  
• Wreesmann VB, Oomen KP, Brennan PA.

J Oral Pathol Med. 2022 Nov;51(10):904-910.

• Current classification of vascular anomalies of the head and neck. 

Oomen KPQ, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):830-836.

• A novel classification of carotid body tumors.

Wreesmann VB, Nixon IJ. 

Eur. J. Surg. Oncol. May, 2021

• Management of the contralateral central neck in differentiated thyroid cancer: A contentious issue. 

Shaha AR, Tuttle RM, Wreesmann VB. 

Eur. J. Surg. Oncol. 2021 Apr;47(4):717-719.

• Improvement of oral cancer screening quality and reach: The promise of artificial intelligence.
•  
• Kar A, Wreesmann VB, Shwetha V, Thakur S, Rao VUS, Arakeri G, Brennan PA.

J Oral Pathol Med. 2020 Mar 11

• The risk-benefit ratio of chemoradiation treatment in head and neck squamous cell carcinoma: value of extranodal spread and margin status. 

Ammar M, Wreesmann VB. 

Journal of ENT Masterclass, Yearbook 2018, Volume 11, Nr. 1, December 1st, 2018

• Nasal obstruction secondary to an inverted midline supernumerary tooth. 

Jones L, Hilton JM, Heyman J, Viswanathan H, Wreesmann VB, Hayes SM. 

Ann R Coll Surg Engl. 2019 Jan;101(1)

• Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. 

Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. 

Oncotarget. 2018 Apr 6;9(26):18198-18213.

• Complete nasal obstruction secondary to pacemaker insertion. 

Jones TL, Wreesmann VB, Nilssen E, Hilton J, Hayes SM. 

Ann R Coll Surg Engl. 2018 May;100(5)

• Optimization of the risk-benefit ratio of differentiated thyroid cancer treatment. 

Nasef HO, Nixon IJ, Wreesmann VB. Eur J Surg Oncol. 

2018 Mar;44(3):276-285. Review.

• The risk/benefit ratio of differentiated thyroid cancer treatment: Exploring treatment de-escalation. 

Wreesmann VB; on behalf of EJSO. 

Eur J Surg Oncol. 2018 Mar;44(3):275.

• Aggressive differentiated thyroid cancer. 

Janjua N, Wreesmann VB. 

Eur J Surg Oncol. 2018 Mar;44(3):367-377. Review.

• Role of extracapsular nodal spread and surgical margin status in defining high-risk head and neck squamous cell carcinoma and its treatment intensity. 

Wreesmann VB. 

International Journal of Head and Neck Surgery, April-June 2017; 8(2): 76-83.

• An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.              

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. 

Thyroid. 2016 Mar;26(3):373-80.

• Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. 
•  
• Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG.

Head Neck. 2016 Apr;38 Suppl 1:E1192-9.

• Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. 

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. 

Ann Surg Oncol. 2015 Jul 28.

• Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
•  
• Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.

Thyroid. 2015 May;25(5):503-8.

• Head and neck squamous cell carcinoma in young patients.

van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ. 

Oral Oncol. 2013 Dec;49(12):1097-102.

• Oral and oropharyngeal squamous cell carcinomas in young patients: The Netherlands Cancer Institute experience. 

van Monsjou HS, M Lopez-Yurda, M. Hauptmann, Balm AJ, van den Brekel MM, Wreesmann VB. 

Head Neck. 2013 Jan;35(1):94-102.

• Oropharyngeal squamous cell carcinoma: a unique disease on the rise?

van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB. 

Oral Oncol. 2010 Nov;46(11):780-5.

• Closure of tracheoesophageal fistula with prefabricated revascularized bilaminar radial forearm free flap.

Wreesmann VB, Smeele LE, Hilgers FJ, Lohuis PJ. 

Head Neck. 2009 Jun;31(6):838-42.

• Clinical impact of molecular analysis on thyroid cancer management.

Wreesmann VB, Singh B. 

Surg Oncol Clin N Am. 2008 Jan;17(1):1-35.

Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. 

van den Broek GB, Wreesmann VB, van den Brekel MW, Rasch CR, Balm AJ, Rao PH. 

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4386-91.

• Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.

Wang SJ, Wreesmann VB, Bourguignon LY. 

Head Neck. 2007 Jun;29(6):550-8.

• Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
•  
• Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ.

ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25. Epub 2007 Apr 4.

• Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
•  
• Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R.
•  
• Surgery. 2006 Dec;140(6):899-905; discussion 905-6.

• Repetitive endoscopic sinus surgery failure: a role for radical surgery?

Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. 

Otolaryngol Head Neck Surg. 2006 Apr;134(4):586-91.

• MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.
•  
• Patel KN, Maghami E, Wreesmann VB, Shaha AR, Shah JP, Ghossein R, Singh B.
•  
• Surgery. 2005 Dec;138(6):994-1001; discussion 1001-2.

• Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities.

Wreesmann VB, Singh B. 

J Oral Pathol Med. 2005 Sep;34(8):449-59. Review.

• Molecular profiling of tumor progression in head and neck cancer.
•  
• Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G.
•  
• Arch Otolaryngol Head Neck Surg. 2005 Jan;131(1):10-8.

• Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck.

Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B. 

J Clin Oncol. 2004 Oct 1;22(19):3965-72.

• Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.

Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Genes Chromosomes Cancer. 2004 Aug;40(4):355-64.

• Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.

Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B. 

Cancer Res. 2004 Jun 1;64(11):3780-9.

• Genetic abnormalities associated with nodal metastasis in head and neck cancer.

Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, Schnaser EA, Sacks PG, Singh B. 

Head Neck. 2004 Jan;26(1):10-5.

• Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.
•  
• Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B.
•  
• J Natl Cancer Inst. 2003 Nov 19;95(22):1718-21.

• Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.

Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, Kraus D, Shah JP, Rao PH. 

BMC Genet. 2002 Nov 14;3:22. Epub 2002 Nov 14.

• Genome-wide appraisal of thyroid cancer progression.
•  
• Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B.
•  
• Am J Pathol. 2002 Nov;161(5):1549-56.

• Refractory chronic sinusitis: evaluation of symptom improvement after Denker’s procedure.
•  
• Wreesmann VB, Fokkens WJ, Knegt PP.
•  
• Otolaryngol Head Neck Surg. 2001 Nov;125(5):495-500.

• Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis.
•  
• Wreesmann V, van Eijck CH, Naus DC, van Velthuysen ML, Jeekel J, Mooi WJ.
•  
• Histopathology. 2001 Feb;38(2):105-10.

• Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
•  
• Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH.
•  
• Surgery. 2000 Dec;128(6):888-93;discussion 893-4.

Abstracts (Presentations at scientific meetings):

• Genome-wide screening for genetic prognostic factors in papillary thyroid carcinoma.
•  
• Wreesmann VB, Ghossein RA, Poluri A, Shaha AR, Tuttle RM, Shah JP Rao PH, Singh B.

Fifth International Conference on Head and Neck Cancer San Francisco, CA, July 2000.

• Hierarchical Clustering (HC): a Novel Approach to Evaluating the Prognostic Value of Laboratory Parameters in Patients (Pts) Undergoing Chemoradiation Treatment (CRT) for Advanced Laryngopharyngeal Carcinoma (LPC). 

Singh B, Pfister D, Wreesmann VB, Li R, Gogineni S, Bosl G, Hoffman RH, Shah JP, Rao PH. 

37th Annual Meeting of the American Society of Clinical Oncology; New Orleans LA, May 2001.

• Gain of 1q is unique to the tall cell variant of papillary thyroid cancer.

Wreesmann VB, Ghossein RA, Tuttle RM, Shaha AR, Robbins R, Shah JP, Rao PH, Singh B. 

73rd annual meeting of the American Thyroid Association, Washington D.C. November 2001.

• MUC1 is a target of 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Shah JP, Rao PH, Ghossein RG, Singh B. 

Annual Meeting of the New York Head and Neck Society, New York, NY, March 2002.

• Genome wide screening identified gains and losses as independent prognostic variables in patients with head and neck squamous cell carcinoma (HNSCC). 

Singh B, Wreesmann VB, Thaler HT, Shi W, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH. 

38th Annual Meeting of the American Society of Clinical Oncology; Orlando, Fl May 2002.

• p53 inactivation by human papillomavirus (HPV) in Fanconi anemia associated squamous cell carcinoma. 

Kutler DI, Goberdhan A, Wreesmann VB, Giampietro PF, Auerbach AD, Singh B. 

The Sixth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer; Washington D.C.; October 2002.

• Identification of novel prognostic factors in head and neck squamous cell carcinoma. 
•  
• Wreesmann VB, Shi W, Thaler HT, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Molecular profiling of aggressive papillary thyroid cancer: prognostic significance of MUC1 alterations. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein RA, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Chromosomal aberrations in Fanconi anemia-associated squamous cell carcinomas differ from sporadic squamous cell carcinomas from the general population. 

Kutler DI, Rao PH, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

• Molecular classification of Fanconi anemia(FA)-associated head and neck squamous cell carcinoma (HNSCC) using oligonucleotide microarrays. 

Kutler DI, Ganly I, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

•  
• Genotyping follicular cell-derived thyroid neoplasia: a CGH study of 150 cases.

Wreesmann VB, Ghossein RA, Socci N, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Sixth International Conference on Head and Neck Cancer, Washington DC, August 2004.

• Downregulation of Fanconi anemia genes in sporadic squamous cell carcinomas of the head and neck. 

Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. 

208th meeting of the Netherlands Society of Otolaryngology-Head and Neck Surgery, Utrecht, April 7th 2006.

• Extracapsular nodal spread does not predict outcome in clinically node negative oral cavity squamous cell carcinoma. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

AHNS 2013 Annual Meeting, April 10 & 11, 2013, Orlando Florida.

• Minor (<2mm) extracapsular spread is not an adverse predictor of outcome in metastatic squamous cell carcinoma of the oral cavity. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. Presented at the AHNS 2014 Annual Meeting, July 2014, New York, New York.

Books, Chapters:

• Molecular Biology as applied to Head and Neck Oncology

Wreesmann VB, Singh B.

Stell and Maran's Textbook of Head and Neck Surgery and Oncology

Fifth Edition

Chapter, edited by John Watkinson and Ralph Gilbert

• Molecular-Cytogenetic Characterization of Head and Neck Cancer: Identification of molecular prognostic factors and targets of therapy

Wreesmann VB, Singh B.

Book, Amsterdam 2004

Reviewed in: Head and Neck: Volume 29, Issue 1, pages 82–83, January 2007

• Open Conservation Surgery for Laryngeal Cancer

Wreesmann VB, Ganly I

Scott-Brown's Otorhinolaryngology and Head and Neck Surgery, Eighth Edition

Chapter 27

CRC Press, Taylor-Francis Group, June 12th, 2018

• Molecular Oncology

Wreesmann V.B.

Self-Assessment in Head and Neck Surgery and Oncology, First Edition

Chapter 21

Elsevier 2014

Research grants:

Netherlands Cancer Institute “Startgeld” Grant 2008

Project: Fanconi anemia in head and neck cancer

Principal investigators: Wreesmann VB, van den Brekel MW, Balm AJM, Vens C.

Amount granted: 300.000 euro

Formation et expertise
2010/2016 Faculté de médecine de l'Université d'Afyon Kocatepe
2017/2022 SBÜ Antalya Formation et recherche Hôpital Clinique ORL Formation de spécialisation médicale

Expérience
Centre de santé communautaire Afyonkarahisar Sinanpaşa 2016/2017
Hôpital de formation et de recherche d'Antalya 2017/2023
Hôpital d'État Dinar d'Afyonkarahisar 2023/2024

Prof. Dr. Celil Göçer is a respected ENT specialist known for his work in otolaryngology. He has published over 30 scientific articles in international journals. His research covers hearing loss, laryngeal cancer, sinus diseases, rare conditions, and new surgical techniques. He has also co-authored ENT books and written chapters for major surgical references.

Dr. Göçer often presents at national and international conferences. He shares research on cochlear implants, paranasal tumors, and how hearing aids affect tinnitus in older adults. He is recognized for his skill in clinical care and surgical training, especially in stapedectomy procedures.

He received advanced training at the House Ear Institute in the USA. Since 2011, he has been a professor at Lokman Hekim Health Group, where he helps shape ENT practice and research in Turkey.

Prapas Teerakul, docteur en médecine

Spécialiste en oto-rhino-laryngologie

Diplômé (MD de)

Docteur en médecine, Faculté de médecine, Hôpital Ramathibodi, Université Mahidol

Les spécialistes dans ce domaine sont appelés oto-rhino-laryngologistes, oto-rhino-laryngologistes, chirurgiens de la tête et du cou ou chirurgiens ou médecins ORL.

Certificats

Certificat d'oto-rhino-laryngologie, hôpital Ramathibodi

Expérience professionnelle

Professeur adjoint, Département d'oto-rhino-laryngologie, Faculté de médecine, Hôpital Ramathibodi, Université Mahidol

Postes actuels

Oto-rhino-laryngologiste à l'hôpital Intrarat

Parcours académique et professionnel

• Éducation:
  • 1990–1996 : Faculté de médecine de l’Université Hacettepe (MD).
  • 1996–2000 : Résidence en ORL à l’hôpital de formation et de recherche d’Ankara.
  • 2002 : Formation avancée au House Ear Institute, Los Angeles, USA.
• Expérience professionnelle :
  • Divers rôles, notamment celui de chercheur, spécialiste et chef dans d’éminents hôpitaux en Turquie.
  • Depuis 2011 : Professeur au Lokman Hekim Health Group, spécialisé dans les maladies ORL.

Principales réalisations et contributions à la recherche

• Travaux publiés :
  • Plus de 30 articles scientifiques dans des revues internationales sur des sujets ORL tels que la perte auditive, le cancer du larynx et les affections des sinus.
  • Les sujets abordés comprennent les maladies rares, les innovations chirurgicales et les évaluations radiologiques.
  • Co-auteur d'ouvrages liés à l'ORL et de chapitres traduits dans des références chirurgicales notables.
• Présentations de conférence :
  • Présentateur fréquent lors de réunions scientifiques nationales et internationales.
  • A réalisé des études révolutionnaires sur les implants cochléaires, les tumeurs paranasales et les effets des prothèses auditives sur les acouphènes gériatriques.
• Prix et reconnaissances :
  • Reconnu pour l’excellence de ses pratiques cliniques et de ses modèles de formation chirurgicale, notamment en stapédectomie.

Intérêts cliniques et de recherche

• Maladies de l'oreille, du nez et de la gorge, en mettant l'accent sur :
  • Troubles auditifs (neuro-sensoriels, de transmission, liés à l'âge).
  • Affections rhinologiques, y compris sinusites et pathologies des muqueuses.
  • Cas ORL oncologiques, notamment cancers rares du larynx et des sinus paranasaux.

Formation et développement professionnel à l'international

• J'ai suivi plusieurs cours spécialisés au House Ear Institute (États-Unis) axés sur la chirurgie et la pathologie de l'os temporal.
• Participation à des ateliers et conférences avancés tels que l'American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF).

Publications et citations

• Rédacteur d’études à fort impact citées dans des revues de premier plan.
• Contributions à la compréhension des troubles ORL grâce à des méthodes de recherche innovantes, telles que la dissection de l'os temporal et l'immunohistochimie.

Le professeur Celil Göçer est un spécialiste reconnu de l'ORL dont l'expertise clinique et les contributions académiques ont grandement influencé le domaine. Il est très apprécié pour ses approches chirurgicales innovantes et son dévouement à l'avancement des connaissances médicales.

Professor Dr. Wolfgang Gstoettner is a leading specialist in ear, nose, and throat (ENT) medicine. He is the Head of the University Hospital ENT Clinic at the Medical University of Vienna. Dr. Gstoettner is known for his pioneering work, including Austria’s first active middle ear and auditory brain stem implantations.

He is an expert in head and neck surgery and has over 30 years of surgical experience. Dr. Gstoettner has held important academic and leadership positions. He served as President of the Austrian Society of Otorhinolaryngology and is a board member of several international ENT organizations.

Dr. Gstoettner has published extensively and is ranked among the top ENT researchers in German-speaking countries. He serves on editorial and advisory boards of major ENT journals. He is also a member of respected societies, such as the Politzer Society and the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum.

Dr. Carlos Manuel Pollán Guisasola is a consultant ENT surgeon at Centro Médico Teknon and Hospital Germans Trias i Pujol in Barcelona. He specializes in endoscopic skull base surgery, head and neck oncology, and robotic surgery using the Da Vinci system. He earned his medical degree from the University of Santiago de Compostela. He completed his residency in Otorhinolaryngology through the MIR program at Vall d’Hebron University Hospital.

Dr. Pollán received advanced clinical training at the University of Pittsburgh and the University Hospital of Pisa. He leads the robotic head and neck surgery program at his hospitals. He is a faculty member at the ENT Teaching Unit of Germans Trias i Pujol. Dr. Pollán has published many peer-reviewed articles and frequently lectures at national and international conferences.

Spécialisation en chirurgie otologique et otoneurologie :

- Pathologie ORL chez l'adulte

- Traitement des pathologies auditives

- Reconstruction du tympan

- Perte auditive neurosensorielle

Le docteur est diplômé de la Faculté de médecine et de chirurgie de l'Université centrale du Venezuela. Il est également titulaire d'un diplôme en biologie de l'Université Villanova (États-Unis).

Spécialiste en oto-rhino-laryngologie (Hôpital Vargas Caracas).

Spécialiste en chirurgie otologique et otoneurologie. Otologie García Ibáñez, Institut du Centre d'Oto-rhino-laryngologie.

Actuellement, il combine sa pratique au Centre Médical Teknon avec son travail d'oto-rhino-laryngologiste au CEM de Vilassar de Mar.

Expérience professionnelle :

2016 : ORL, Centro Medico Game, Sant Boi de Llobregat.

2016 : Otorhinolaryngologiste, CORL Gran Via, Barcelone.

2010 : Oto-rhino-laryngologiste, Centre Médical Teknon, Barcelone.

1996 : Oto-rhino-laryngologiste, Centre médical Teknon, Service des urgences.

1996-2016 : Oto-rhino-laryngologiste, Hôpital Delfos, Service des Urgences, Barcelone.

1996–2015 : Otorhinolaryngologiste, Clínica del Remei, Service des Urgences, Barcelone.

1997 : Otorhinolaryngologiste, CEM Vilassar de Mar.

1993-1995 : ORL, Polyclinique de Barcelone.

Dr. Avraam Abergel is a specialist in Otolaryngology and Hearing Impairment. He is the Deputy Head of the Department of Otolaryngology and the Acting Director of the Department of Hearing Impairment at Sourasky Medical Center.

Forbes ranked Dr. Abergel among the best doctors in Israel in 2021. He is known for his skill in advanced endoscopic sinus surgery, transsphenoidal pituitary tumor removal, and lacrimal duct procedures. He has a strong record in treating snoring, sleep apnea, and both benign and malignant tumors of the head and neck. This includes thyroid, throat, salivary gland, and nasopharyngeal cancers.

2017 - 2018

Université des sciences de la santé, hôpital de recherche sur les pratiques de santé de Tepecik

2015 - 2018

Université des sciences de la santé, hôpital de recherche sur les pratiques de santé de Tepecik

2013 - 2018

Université des sciences de la santé, hôpital de recherche sur les pratiques de santé de Tepecik

2013

Articles publiés dans 28 revues internationales à comité de lecture

Articles et posters présentés lors de 17 réunions scientifiques internationales

Articles publiés dans 55 revues nationales à comité de lecture

56 communications et posters présentés lors de réunions scientifiques nationales

14 publications référencées dans des revues nationales et internationales à comité de lecture

35 modérateurs de conférences nationales en direct

10 cours nationaux suivis

8 conférences internationales suivies

32 réunions avec des participants nationaux

6 Rencontres Internationales

Dr. Ari Derowe is a Pediatric Otolaryngologist with 32 years of clinical experience. He leads the Pediatric Otolaryngology Unit at Ichilov Sourasky Medical Center in Tel Aviv. Dr. Derowe earned his medical degree and completed his specialization in Otorhinolaryngology at Sackler University. He also trained at Kaplan and Meir Hospitals.

Dr. Derowe teaches at Stanford School of Medicine. He is known for his work in pediatric ENT surgery. He is a member of the Israel Medical Association, the Israeli and American Societies of Otolaryngology, and the American Bronchoesophageal Association. These memberships show his strong professional reputation both in Israel and internationally.

2013

Hôpital Florence Nightingale d'Istanbul

Oreille, nez, gorge

1998 - 2013

Hôpital chirurgical d'Istanbul

Oreille, nez, gorge

1996 - 1997

Hôpital Etfal de Şişli

Chef adjoint ORL

1992 - 1996

Hôpital Méthodiste de l'Indiana

Oreille, nez, gorge

1992 - 1996

Institut Gustave Roussy, France

Médecin observateur

1992 - 1995

Clinique du Professeur Frédéric Chabolle à Suresnes Hôpital Foch

Médecin assistant

1989 - 1992

Hôpital Etfal de Şişli

Chef adjoint ORL

1985 - 1989

Şişli Etfal et hôpital universitaire de Marmara

Spécialisation ORL

Le docteur Ophir Hendzel est un oto-rhino-laryngologiste israélien certifié, d'origine américaine, spécialisé dans les implantations cochléaires et les interventions chirurgicales complexes en otologie et en neurobiologie. Il est titulaire d'un diplôme de médecine en oto-rhino-laryngologie de l'Université hébraïque de Jérusalem et a suivi une formation spécialisée en chirurgie de la base du crâne otique et latérale, en chirurgie de l'os temporal et en chirurgie de la base du crâne latérale, respectivement à la Harvard Medical School, au House Ear Institute et à l'Université Saint Louis. Son expérience professionnelle comprend la certification au sein de l'unité des implants cochléaires du Sourasky Medical Center et du service d'oto-rhino-laryngologie de l'Assuta Clinic. Il est membre de la Société israélienne d'oto-rhino-laryngologie et de chirurgie de la tête et du cou, de la Société israélienne d'otologie et de la Société internationale d'otologie.

Oto-rhino-laryngologiste

Dr. Mustafa Ibas is an ENT specialist. He has clinical experience in childhood ENT diseases, rhinoplasty, endoscopic sinus surgery, ear diseases, hearing loss, head and neck surgery, salivary gland diseases, and maxillofacial trauma surgery. Dr. Ibas worked as an ENT specialist at Ankara Etimesgut Sait Ertürk State Hospital from 2023 to 2024. He also served at Mardin Midyat State Hospital from 2022 to 2023. He completed his assistant physician training at Health Sciences University Ankara Training and Research Hospital between 2017 and 2022.

Dr. Ibas has published several peer-reviewed articles. His research covers topics such as preauricular iatrogenic epidermoid cysts, dermatofibrosarcoma protuberans, the use of probiotics in otitis media, and the anti-inflammatory effects of naringenin in otitis media. He earned his medical degree from Necmettin Erbakan University Meram Faculty of Medicine.